Skip to main content
logo
Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
18.24
-0.02 (-0.11%)
Oct 26, 2026, 10:18 AM EDT - Market open

Vor Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
627.78-695.98-116.91-117.86-92.09-68.9
Depreciation & Amortization
0.092.893.533.492.531.43
Loss (Gain) From Sale of Assets
-3.3-0.02---
Asset Writedown & Restructuring Costs
-45.22177.38----
Stock-Based Compensation
33.418.919.8513.3610.74.32
Other Operating Activities
-757.84340.583.890.073.573.19
Change in Accounts Payable
10.9110.932.242.851.110.41
Change in Other Net Operating Assets
-9.22-0.72-2.24-2.2-10.95-9.59
Operating Cash Flow
-140.09-142.71-99.66-100.29-85.14-69.14
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.73-0.94-0.23-1.07-8.46-3.89
Sale of Property, Plant & Equipment
-0.8----
Investment in Securities
-348.26-48.6697.0972.08-85.63-87.76
Investing Cash Flow
-348.99-48.896.8671.01-94.09-91.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
580.29505.3956.054.84117.14189.75
Repurchase of Common Stock
-0.17-0.25-0.33-1.19--
Other Financing Activities
-176.01-1.33-2.33-0.72--2.22
Financing Cash Flow
404.11503.8153.392.94117.14232.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-84.96312.2950.59-26.35-62.172.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-140.81-143.65-99.89-101.36-93.61-73.04
Free Cash Flow Growth
------
Free Cash Flow Per Share
-4.53-14.55-29.07-30.17-47.33-43.69
Levered Free Cash Flow
-79.5-180.67-60.89-58.02-51.87-48.67
Unlevered Free Cash Flow
-79.5-180.67-60.89-58.02-51.87-48.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
1.6910.210.010.65-9.84-9.19
SEC Filings: 10-K · 10-Q